Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction

Pediatrics

Volumn 120, Issue 5, 2007, Pages

  Jean Philippe, Patrick ^a,e   Freedman, Abigail ^a,c   Chang, Mary Wu ^a,d   Steinbergd, Sharon P ^b   Gershon, Anne A ^b   LaRussa, Philip S ^b   Borkowsky, William ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d Farmington   (United States)

^e HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Immunodeficiency; Vaccine adverse reaction; Varicella

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHICKENPOX VACCINE;

ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CHICKENPOX; DRUG SAFETY; FEMALE; HUMAN; IMMUNE DEFICIENCY; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; T CELL DEPLETION; VACCINATION;

CHICKENPOX; CHICKENPOX VACCINE; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; T-LYMPHOCYTES;

EID: 36048978606     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2004-1681     Document Type: Article

References (43)

1. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45(RR-11):1-36
2. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2(7892):1288-1290
3. Takahashi M, Kamiya H, Baba K, Asano Y, Ozaki T, Horiuchi K. Clinical experience with Oka live varicella vaccine in Japan. Postgrad Med J. 1985;61(suppl 4):61-67
4. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med. 1984;310:1409-1415
5. Gershon AA, Steinberg SP, Gelb L, et al. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA. 1984;252:355-362
6. Leung TF, Chik KW, Li CK, et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant. 2000;25:167-172
7. Pandya A, Wasfy S, Hébert D, Allen UD. Varicella-zoster infection in pediatric solid-organ transplant recipients: a hospitalbased study in the prevaricella vaccine era. Pediatr Transplant. 2001;5:153-159
8. Jura E, Chadwick EG, Josephs SH, et al. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1989;8:586-590
9. Rongkavilit C, Mitchell CD, Nachman S. Varicella zoster infection in HIV-infected children. Paediatr Drugs. 2000;2:291-297
10. Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis. 1996;174(suppl 3):S330-S334
11. + T cells. J Infect Dis. 2006;194:247-255
12. Prevention of varicella: update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-6):1-5
13. Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM. Attenuation of the vaccine Oka strain of varicellazoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol. 1998;72:965-974
14. Grossberg R, Harpaz R, Rubtcova E, Loparev V, Seward JF, Schmid DS. Secondary transmission of varicella vaccine virus in a chronic care facility for children. J Pediatr. 2006;148:842-844
15. LaRussa P, Steinberg S, Meurice F, Gershon A. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J Infect Dis. 1997;176:1072-1075
16. Brunell PA, Argaw T. Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster. Pediatrics. 2000;106(2). Available at: www.pediatrics.org/cgi/content/full/106/2/e28
17. Sharrar RG, LaRussa P, Galea SA, et al. The postmarketing safety profile of varicella vaccine. Vaccine. 2000;19:916-923
18. Brunell PA, Taylor-Wiedeman J, Geiser CF, Frierson L, Lydick E. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics. 1986;77:53-56
19. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med. 1991;325:1545-1550
20. Uebe B, Sauerbrei A, Burdach S, Horneff G. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child. Eur J Pediatr. 2002;161:442-444
21. Arvin AM. Varicella vaccine: genesis, efficacy, and attenuation. Virology. 2001;284:153-158
22. Arvin AM, Koropchak CM, Williams BR, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis. 1986;154:422-429
23. Asano Y, Itakura N, Hiroishi Y, et al. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis. 1985;152:863-868
24. Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine [published correction appears in JAMA. 2000;284:3129]. JAMA. 2000;284:1271-1279
25. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287:606-611
26. Staat MA, Meinzen-Derr J, Welch T, et al. Varicella-related hospitalization and emergency department visit rates, before and after introduction of varicella vaccine, among white and black children in Hamilton County, Ohio. Pediatrics. 2006;117(5). Available at: www.pediatrics.org/ cgi/content/full/117/5/e833
27. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294:797-802
28. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450-458
29. Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics. 1986;78(4 pt 2):757-762
30. Brunell PA, Geiser CF, Novelli V, Lipton S, Narkewicz S. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics. 1987;79:922-927
31. Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med. 1989;320:892-897
32. Gershon AA, LaRussa P, Steinberg S. The varicella vaccine: clinical trials in immunocompromised individuals. Infect Dis Clin North Am. 1996;10:583-594
33. Leung TF, Li CK, Hung ECW, et al. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol. 2004;72:353-357
34. Chaves Tdo S, Lopes MH, de Souza VA, et al. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplant. 2005;9:192-196
35. Weinberg A, Horslen SSP, Kaufman SS, et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant. 2006;6:565-568
36. Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: seventy-seven cases. Pediatrics. 1975;56:388-397
37. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 1992;66:1016-1020
38. Ardron P, La Russa P, Steinberg S, Caserta M. Severe vaccineassociated rash following varicella vaccine (VARIVAX) in an adolescent with primary sclerosing cholangitis (PSC) [abstract]. Pediatr Res. 1996;39:165A
39. Ghaffar F, Carrick K, Rogers BB, Margraf LR, Krisher K, Ramilo O. Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency. Pediatr Infect Dis J. 2000;19:764-766
40. Kramer JM, LaRussa P, Tsai WC, et al. Disseminated vaccine strain varicella as the acquired immunodeficiency syndromedefining illness in a previously undiagnosed child. Pediatrics. 2001;108(2). Available at: www.pediatrics.org/cgi/content/full/108/2/e39
41. Levy O, Orange JS, Hibberd P, et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis. 2003;188:948-953
42. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis. 2003;188:954-959
43. Lohiya GS, Tan-Figueroa L, Reddy S, Marshall S. Chickenpox and pneumonia following varicella vaccine. Infect Control Hosp Epidemiol. 2004;25:530-530